Duration of a Clozapine Trial in Neuroleptic-Resistant Schizophrenia

Archives of General Psychiatry

Volumn 46, Issue 7, 1989, Pages 672-

  Meltzer, Herbert Y ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DIBENZAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

CLINICAL TRIAL; HUMAN; LETTER; PSYCHOLOGY; RATING SCALE; SCHIZOPHRENIA; TIME;

ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS; CLOZAPINE; DIBENZAZEPINES; HUMAN; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS;

EID: 0024706878     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1989.01810070098017     Document Type: Article

References (6)

1. Kane J, Honigfeld G, Singer J, Meltzer HY, Clozaril Collaborative Study Group. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789-796.
2. Povisen UJ, Noring U, Fog R, Gerlach J. Tolerability and therapeutic effect of clozapine: a retrospective investigation of 216 patients treated with clozapine for up to 12 years. Acta Psychiatr Scand. 1985;71:176-185.
3. Kulia S, Merttinen E. Long-term effect of clozapine in schizophrenia: a retrospective study of 108 chronic schizophrenics treated with clozapine for up to 7 years. Nord Psychiatr Tidsskrift. 1986;40:225-230.
4. Lindström LH. The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years. Acta Psychiatr Scand. 1988;71:524-529.
5. Marder SR, Van Putten T. Who should receive clozapine? Arch Gen Psychiatry. 1988;45:865-867.
6. Meltzer HY, Bastani B, Kown KY, Ramirez L, Burnett S, Sharpe J. A prospective study of clozapine in treatment resistant schizophrenic patients, I: preliminary report. Psychopharmacology. In press.